Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
While the FDA doesn't require a warning about ED, some medical research suggests a possible link
ENNUMO joins Accord BioPharma's existing oncology supportive care portfolio: UDENYCA (pegfilgrastim-cbqv), its first long-acting pegfilgrastim biosimilar, and FILKRI (filgrastim-laha), its short-acting granulocyte colony-stimulating factor biosimilar approved in February 2026
Redefine wellness with science Wellness starts with metabolic health, encompassing energy, strength, and recovery not just the number on the scale
This naturally occurring antioxidant is well-tolerated by all skin types, including those with sensitive and acne-prone skin
Take as a dietary supplement
US$ 21.46
US$ 25.15
US$ 28.84
US$ 29.29
